CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹951 Cr | ₹754 Cr | ₹536 Cr | ₹288 Cr | ₹371 Cr |
What is the latest Net Current Assets ratio of CONCORD BIOTECH ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹951 Cr |
| Mar2024 | ₹754 Cr |
| Mar2023 | ₹536 Cr |
| Mar2022 | ₹288 Cr |
| Mar2021 | ₹371 Cr |
How is Net Current Assets of CONCORD BIOTECH Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹951 Cr | 26.14 | |
| Mar2024 | ₹754 Cr | 40.72 | |
| Mar2023 | ₹536 Cr | 85.79 | |
| Mar2022 | ₹288 Cr | -22.30 | |
| Mar2021 | ₹371 Cr | - | |
Compare Net Current Assets of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,771.1 Cr | -4.7% | 18% | -36.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -4.7% |
18% |
-36.4% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses